Allergy to human recombinant DNA-insulin: 3 Cases with generalized immediate allergic reactions;Allergie à l'insuline humaine recombinante: À propos de 3 cas avec manifestations immédiates généralisées

Revue Francaise d'Allergologie et d'Immunologie Clinique

Volumn 43, Issue 3, 2003, Pages 165-169

  Imiela, A ^a   Tavernier, J Y ^b   Carrotte Lefebvre, I ^b   Devemy, F ^b   Delaporte, E ^a   Lamblin, C ^b  

^a LILLE UNIVERSITY HOSPITAL   (France)

^b Centre Hospitalier de LENS   (France)

Author keywords

Allergy; Case report; Generalized reaction; Insulin; Urticaria

Indexed keywords

INSULIN ASPART; INSULIN LISPRO; ISOPHANE INSULIN; NEUTRAL INSULIN; PIG INSULIN; RECOMBINANT HUMAN INSULIN;

ADULT; ARTICLE; ATOPY; CASE REPORT; DIABETES CONTROL; DNA BINDING; DRUG HYPERSENSITIVITY; DRUG SAFETY; FEMALE; GRAVITY; HUMAN; INJECTION SITE; INSULIN BINDING; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; REACTION ANALYSIS; SKIN TEST; SYSTEMIC DISEASE;

EID: 0037501351     PISSN: 03357457     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0335-7457(03)00045-5     Document Type: Article

References (16)

1. Sodoyez JC, Koch M, Sodoyez-Goffaux M. Anticorps anti-insuline: méthodologie et implications cliniques. Diabète Metab 1991;17: 255-69.
2. Barbaud A, Got I, Trechot P, Noirez V, Schmutz JL. Allergies cutanées et insulinothérapie: aspects récents, conduite à tenir. Ann Dermatol Venereol 1996;123:214-8.
3. Schernthaner G. Immunogenicity and allergenic potential of animal and human insulins. Diabetes Care 1993;16:155-65.
4. Grammer LC, Roberts M, Buchanan TA, Fitzsimons R, Metzger BE, Patterson R. Specificity of immunoglobulin E and immunoglobulin G against human (recombinant DNA) insulin in human insulin allergyand resistance. J Lab Clin Med 1987;109:141-6.
5. Lluch-Bernal M, Fernandez M, Herrera-Pombo JL, Sastre J. Insulin lispro, an alternative in insulin hypersensitivity. Allergy 1999;54: 186-7.
6. Kumar D. Lispro analog for treatment of generalized allergy to human insulin. Diabetes Care 1997;20:1357-9.
7. Grammer LC, Chen PY, Patterson R. Evaluation and management of insulin allergy. J Allergy Clin Immunol 1983;71:250-4.
8. Lee AY, Chey WY, Choi J, Jeon JS. Insulin-induced drug eruptions and reliability of skin tests. Acta Derm Venereol 2002;82:114-7.
9. De Shazo RD, Mather P, Grant W, Carrington D, Frentz JM, Lueg M, et al. Evaluation of patients with local reactions to insulin with skin tests and in vitro techniques. Diabetes Care 1987;10:330-6.
10. Plantin P, Sassolas B, Guillet MH, Tater D, Guillet G. Accidents cutanés allergiques aux insulines, Aspects actuels à propos de 2 cas. Ann Dermatol Venereol 1988;115:813-7.
11. Ganz MA, Unterman T, Roberts M, Uy R, Sahgal S, Samter M, et al. Resistance and allergy to recombinant human insulin. J Allergy Clin Immunol 1990;86:45-51.
12. Panczel P, Hosszufalusi N, Horvath MM, Horvath A. Advantage of insulin lispro In suspected insulin allergy. Allergy 2000;55:409-10.
13. Gonzalo MA, De Argila D, Revenga F, Garcia JM, Diaz J, Morales F. Cutaneous allergy to human (recombinant DNA) insulin. Allergy 1998;53:106-7.
14. Airaghi L, Lorini M, Tedeschi A. The insulin analog aspart: a safe alternative in insulin allergy. Diabetes Care 2001;24:2000.
15. Yasuda H, Nagata M, Moriyama H, Fujihira K, Kotani R, Yamada K, et al. Human insulin analog insulin aspart does not cause insulin allergy. Diabetes Care 2001;24:2008-9.
16. Wessbecher R, Kiehn M, Stoffel E, Moll I. Management of insulin allergy. Allergy 2001;56:919-20.